Searched for
CANCER DRUG MARKUPS
Fortis, Apollo, other hospital stocks slump up to 10% in 2 days after SC questions steep markups. Buying opportunity?Hospital stocks extended losses for a second session after the Supreme Court questioned steep markups on cancer drugs and raised concerns o...- Jefferies picks 6 hospitals as Buy after steep correction offers 'excellent' entry points. Check target priceJefferies has maintained a Buy rating on six hospital stocks, including Apollo Hospitals and Fortis Healthcare, following a sharp correctio...
- Hospital stocks slip after SC query on steep cancer drug markupsIn a landmark ruling, the Supreme Court of India highlighted troubling markups on cancer drugs enforced by hospitals, urging a probe into r...
- SC seeks 16% MRP cap on medicines, flags huge cancer drug markupsThe Supreme Court has raised concerns regarding inflated prices of essential medicines, particularly cancer drugs, sold at exorbitant marku...
- Siang project not just hydropower, vital for national security: Arunachal Pradesh CM Pema KhanduArunachal Pradesh chief minister Pema Khandu said that the Siang Upper Multi-Purpose Project should not be viewed merely through the prism ...
- Cancer drug costs Rs 2,700, sells for Rs 27,000: SC questions 10x markup at hospitalsThe Supreme Court has questioned steep markups on cancer drugs and asked the Centre to examine a uniform 16% margin on all medicines. The c...
- TrumpRx website 2025: direct-to-consumer prescription drug platform and Pfizer discount deal explainedPresident Donald Trump announced TrumpRx, a government-operated website launching early 2026 for discounted prescription drugs. Pfizer agre...
- UnitedHealth, the company that employed slain CEO Brian Thompson, allegedly overcharged some cancer patients by more than 1,000% for their medicationsUnitedHealth, in which slain CEO Brian Thompson was employed, has been allegedly accused of overcharging patients suffering from dangerous ...
- A $300-billion reason India's drug price cap will stayWhen it comes to intellectual property, it's now understood — and grudgingly accepted — that India's use of compulsory licensing won't go a...
- PM Narendra Modi forced NPPA to relax essential drugs norms: Congress"By forcing the NPPA to withdraw its guidelines the PM has extracted a heavy price from the country’s poor and ailing for his PR exercise i...
- A healthier India: Need to resolve conflict between drug price controls, innovation and affordable healthcareThe debate about essential-medicine pricing and access in India illustrates the difficulties inherent in establishing policies.
Load More
